These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35371309)

  • 1. Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma.
    Chen S; Mao Y; Chen W; Liu C; Wu H; Zhang J; Wang S; Wang C; Lin Y; Lv Y
    J Cancer; 2022; 13(5):1410-1417. PubMed ID: 35371309
    [No Abstract]   [Full Text] [Related]  

  • 2. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma.
    Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W
    J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma.
    Shi M; Jiang Y; Yang L; Yan S; Wang YG; Lu XJ
    J Cell Biochem; 2018 Jun; 119(6):4711-4716. PubMed ID: 29278659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
    Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
    Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
    Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
    World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma.
    Liu W; Hu J; Zhou K; Chen F; Wang Z; Liao B; Dai Z; Cao Y; Fan J; Zhou J
    Onco Targets Ther; 2017; 10():3843-3851. PubMed ID: 28814883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
    Cui X; Wu Y; Wang Z; Liu X; Wang S; Qin C
    Tumour Biol; 2015 May; 36(5):3887-93. PubMed ID: 25596083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma.
    Wang T; Zhu H; Xiao M; Zhou S
    J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
    Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
    J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis.
    Qu Z; Wu J; Wu J; Ji A; Qiang G; Jiang Y; Jiang C; Ding Y
    Oncotarget; 2017 Oct; 8(46):80666-80678. PubMed ID: 29113334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X; Zhao Y; Wang X; Qin L; Hu R
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma.
    Xu H; Dong X; Chen Y; Wang X
    Clin Chem Lab Med; 2018 Feb; 56(3):479-484. PubMed ID: 29252188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y; Zhang C; Zhang P; Guo G; Jiang T; Zhao X; Jiang J; Huang X; Tong H; Tian Y
    Cancer Med; 2018 May; 7(5):1670-1679. PubMed ID: 29573235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating plasma exosomal miRNA profiles serve as potential metastasis-related biomarkers for hepatocellular carcinoma.
    Huang C; Tang S; Shen D; Li X; Liang L; Ding Y; Xu B
    Oncol Lett; 2021 Feb; 21(2):168. PubMed ID: 33552286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
    Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
    Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.